SAN FRANCISCO, CA—A new analysis of the EXCEL trial shows that PCI continues to be noninferior to CABG through 5 years for patients with left main CAD, investigators reported here today. As reported ...
(UPDATED) A statistical deep dive into the EXCEL trial, one that also includes evidence from other revascularization studies in the setting of left main coronary artery disease, shows that there is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results